Jostein Dahle is an accomplished professional in the field of biotechnology and radiation biology, currently serving as the Research and Innovation leader at Akershus universitetssykehus since February 2024, and the Chief Technology Officer at Blue Wave Therapeutics since March 2021. Alongside these roles, Jostein holds multiple positions including Company Owner of Jostein Dahle Consulting, Associate at Alacrita Consulting, and previously served as Chief Scientific Officer and CEO at Nordic Nanovector ASA. Jostein's extensive experience encompasses research leadership, project management, and expertise in radioimmunotherapy and dosimetry. Jostein's academic background includes a PhD in Radiation Biology from the University of Oslo and an MSc in Biophysics from the Norwegian University of Science and Technology, supplemented with executive education from institutions such as INSEAD and London Business School.
Links
Sign up to view 0 direct reports
Get started